Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Historical Holders from Q1 2018 to Q3 2025

Symbol
CDLX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,781,399
Holdings value
$55,357,566
% of all portfolios
0%
Number of holders
81
Number of buys
40
Number of sells
53
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CAS Investment Partners, LLC 9.8% -11% $5,509,951 -$441,820 5,198,067 -7.4% CAS Investment Partners, LLC 19 Aug 2025
VANGUARD GROUP INC 4.6% $5,075,509 2,416,909 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 2.1% $2,307,852 1,098,977 BlackRock, Inc. 30 Jun 2025
As of 30 Sep 2025 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22,781,399 shares of 53,041,500 outstanding shares and own 43% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) own 39% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
CAS Investment Partners, LLC 9.8% 5,198,067 -7.4% 0.56% $12,631,303
VANGUARD GROUP INC 4.5% 2,401,436 -0.64% 0% $5,835,490
BANK OF AMERICA CORP /DE/ 3.1% 1,632,786 +298% 0% $3,967,670
KPS Global Asset Management UK Ltd 2.3% 1,218,830 0% 0.38% $2,961,757
683 Capital Management, LLC 2.2% 1,175,000 -29% 0.26% $2,855,250
WORLDLY PARTNERS MANAGEMENT, LLC 2.2% 1,157,989 0% 1.7% $2,813,913
Quinn Opportunity Partners LLC 2.1% 1,100,000 +900% 0.2% $2,673,000
BlackRock, Inc. 1.8% 971,558 -12% 0% $2,360,887
RBF Capital, LLC 1.5% 800,103 -3.5% 0.09% $1,944,250
JANE STREET GROUP, LLC 1.5% 799,657 +392% 0% $1,943,167
GEODE CAPITAL MANAGEMENT, LLC 1.2% 633,564 +0.16% 0% $1,540,073
CITIZENS FINANCIAL GROUP INC/RI 0.98% 518,663 0.02% $1,260,351
MORGAN STANLEY 0.92% 488,120 +50% 0% $1,186,131
LPL Financial LLC 0.89% 470,124 -55% 0% $1,142,400
UBS Group AG 0.86% 458,066 +113% 0% $1,113,100
MILLENNIUM MANAGEMENT LLC 0.71% 378,761 -30% 0% $920,389
SIMPLEX TRADING, LLC 0.48% 255,349 +252% 0.01% $620,000
STATE STREET CORP 0.43% 227,731 -1.3% 0% $553,386
DIMENSIONAL FUND ADVISORS LP 0.39% 208,430 -33% 0% $506,992
ROYAL BANK OF CANADA 0.36% 190,314 +530% 0% $463,000
RAYMOND JAMES FINANCIAL INC 0.25% 133,255 +36915% 0% $323,810
G2 Investment Partners Management LLC 0.24% 128,132 0.06% $311,361
TWO SIGMA INVESTMENTS, LP 0.24% 125,938 +45% 0% $306,029
CITADEL ADVISORS LLC 0.24% 125,255 0% $304,370
Invesco Ltd. 0.23% 123,149 +23% 0% $299,252

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,781,399 $55,357,566 -$1,193,678 $2.43 81
2025 Q2 24,551,816 $40,388,162 -$6,876,383 $1.64 87
2025 Q1 28,581,930 $52,019,339 -$5,385,580 $1.82 104
2024 Q4 30,318,387 $112,466,412 -$2,088,577 $3.71 105
2024 Q3 30,794,820 $98,563,792 -$20,795,950 $3.20 114
2024 Q2 33,695,414 $276,632,230 -$28,175,573 $8.21 126
2024 Q1 35,620,190 $516,145,492 +$80,060,594 $14.49 145
2023 Q4 77,828 $716,796 +$361,318 $9.21 3
2023 Q3 28,041,121 $463,140,509 +$17,702,466 $16.50 110
2023 Q2 27,412,381 $173,379,386 -$6,527,556 $6.32 107
2023 Q1 28,652,612 $97,279,327 -$6,567,852 $3.40 99
2022 Q4 29,687,135 $171,598,587 -$27,971,318 $5.78 116
2022 Q3 31,170,953 $293,009,519 -$32,121,672 $9.40 114
2022 Q2 31,595,692 $705,103,664 -$47,893,962 $22.31 128
2022 Q1 32,105,855 $1,765,340,508 +$33,440,619 $54.98 143
2021 Q4 32,865,847 $2,172,334,765 +$84,370,855 $66.09 153
2021 Q3 31,144,181 $2,614,210,687 -$72,878,610 $83.94 160
2021 Q2 31,376,638 $3,977,739,304 +$124,455,773 $126.93 187
2021 Q1 30,551,628 $3,353,407,688 +$222,326,760 $109.70 201
2020 Q4 25,263,261 $3,605,983,154 -$45,231,726 $142.77 190
2020 Q3 26,582,576 $1,875,491,237 +$107,136,224 $70.57 158
2020 Q2 25,011,926 $1,750,112,005 +$227,704,225 $69.98 163
2020 Q1 22,082,673 $772,061,581 -$61,475,781 $34.96 138
2019 Q4 23,008,936 $1,446,322,852 +$109,382,419 $62.86 154
2019 Q3 21,149,069 $708,918,095 +$86,798,835 $33.52 115
2019 Q2 19,153,490 $497,331,093 +$81,121,882 $25.98 77
2019 Q1 16,277,081 $269,478,973 +$7,217,515 $16.54 61
2018 Q4 16,093,918 $174,294,975 +$5,020,262 $10.83 60
2018 Q3 11,907,497 $296,625,022 +$46,193,877 $25.04 58
2018 Q2 10,049,202 $217,102,831 +$13,927,748 $21.76 51
2018 Q1 9,527,471 $137,886,708 +$137,886,782 $14.63 50